who made retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide 24 mg & 40

Others are investigating whether adding an amylin analogue like cagrilintide to retatrutide could provide additional satiety benefits beyond what the triple agonist achieves alone

[1] Most are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly, depending on the specific formulation

Feb 24, 2026 After analyzing hundreds of retatrutide vendor listings, testing protocols, and third-party purity reports, one pattern keeps emerging

* FURTHER, when large amounts of wt are lost quickly, nutrient intake becomes more important to ensure adequate #protein, #vitamins, #minerals, etc (to prevent disproportionate loss of #leanmass, and side effects/AEs like #anemia, #fatigue, etc)